InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Arthur David J., Chief Executive Officer. Director active across 1 companies, notably Salarius Pharmaceuticals, Inc.. Cumulatively, 9 disclosures have been logged. Total volume traded: €53k. The latest transaction was disclosed on 26 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
€5703,400 shares@ €0.16770.8% of flow
Common Stock
SEC:0001615219-22-000087:0·
Ideal exit: 20 Feb 2023 (T+270)
€1,76910,000 shares@ €0.17692.6% of flow
Common Stock
SEC:0001615219-22-000069:0·
€49,080139,488 shares@ €0.351971.2% of flow
Common Stock
SEC:0001615219-22-000018:0·
Ideal exit: 28 Nov 2022 (T+270)
€4,9237,939 shares@ €0.620176.2% of flow
Common Stock
SEC:0001615219-21-000096·
€4,9237,939 shares@ €0.62017.1% of flow
Common Stock
SEC:0001615219-21-000096:0·
€1,5352,000 shares@ €0.767723.8% of flow
Common Stock
SEC:0001615219-21-000087·
Ideal exit: 14 May 2022 (T+270)
€1,5352,000 shares@ €0.76772.2% of flow
Common Stock
SEC:0001615219-21-000087:0·
Ideal exit: 14 May 2022 (T+270)
9,822 shares
Common Stock
SEC:0001615219-21-000040·
€4,6179,822 shares@ €0.47016.7% of flow
Common Stock
SEC:0001615219-21-000040:0·
9 of 9 declarations
About Arthur David J.
David J. Arthur is the Chief Executive Officer of Salarius Pharmaceuticals, Inc. He oversees the company's operations and is responsible for implementing growth strategies. With a strong background in the pharmaceutical sector, he leads efforts to develop innovative treatments. His leadership is essential in positioning Salarius as a key player in the healthcare field.
